Trial intelligence / Profile preview

Hemocoagulase Atrox for hemostasis during endoscopic sinus surgery

ChiCTR-IIR-17013833Phase 4Completed

Sponsor
Eye and ENT Hospital of Fudan University
Start
Jul 2009
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of hemocoagulase in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoints: Intraoperative bleeding and Operation time. Started Jul 2009; status: completed.

02

Drugs

hemocoagulase
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on ChiCTR-IIR-17013833.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17013833.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call